Paper
15 December 2003 Plasma etch optimization of a photo-sensitive benzocyclobutene (BCB) planarisation layer for photonic integrated circuit manufacturing
Jason D. Robinson, Bedwyr Humphreys
Author Affiliations +
Proceedings Volume 5260, Applications of Photonic Technology 6; (2003) https://doi.org/10.1117/12.543534
Event: Applications of Photonic Technology, 2003, Quebec City, Québec, Canada
Abstract
Benzocyclobutene (BCB) polymers have demonstrated excellent planarization capabilities. They are procesed using photo patterning or dry etching. A combination process involving both these methods has been developed and optimized for photonic integrated circuits (PICs). Inductively Coupled Plasma (ICP) and Reactive Ion Etching (RIE) are compared as well as soft and hard mask processes. An orthogonal design experiment is demonstrated as an excellent method for evaluating the parameter space of an etch process with variables of table power, ICP power, pressure, and O2/(O2+CF4) ratio. The sensitivities of these variables on etch rate, selectivity and etch profile are discussed. Etch rates of over 1.0 μm/min were achieved with the ICP source, which was in order of magnitude improvement to that of RIE and vertical to positive sloped BCB profiles with excellent mask selelctivity were established.
© (2003) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jason D. Robinson and Bedwyr Humphreys "Plasma etch optimization of a photo-sensitive benzocyclobutene (BCB) planarisation layer for photonic integrated circuit manufacturing", Proc. SPIE 5260, Applications of Photonic Technology 6, (15 December 2003); https://doi.org/10.1117/12.543534
Lens.org Logo
CITATIONS
Cited by 8 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Etching

Plasma etching

Reactive ion etching

Photomasks

Plasma

Ions

Photonic integrated circuits

RELATED CONTENT


Back to Top